Form 4 CORETEC GROUP INC. For: Jun 06 Filed by: Kappers Matthew Joseph
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 ACM Research, Inc. For: Jun 06 Filed by: McKechnie Mark
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form SC 13D/A Zivo Bioscience, Inc. Filed by: Maggiore Christopher D.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 6)*
Zivo Bioscience, Inc.
(Name of Issuer)
Common Stock, $0.001 par value
(Title of Class of Securities)
98978N 101
(CUSIP Number)
Christopher D. Maggiore
4788 Nobles Pond Dr. NW
Canton, OH 44718
248-452-9866
Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
Form 4 Tango Therapeutics, Inc. For: Jun 06 Filed by: Davis Aaron I.
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 D-Wave Quantum Inc. For: Jun 05 Filed by: Michael Emil
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
More SEC Filings
View Older Stories-
Form 4 ARS Pharmaceuticals, For: Jun 07 Filed by: Shah Pratik
-
Form 4 OCCIDENTAL PETROLEUM For: Jun 05 Filed by: BUFFETT WARREN E
-
Form 4/A ARS Pharmaceuticals, For: Jun 04 Filed by: Shah Pratik
-
Form 4 Quince Therapeutics, For: Jun 05 Filed by: Lamond David
-
Form 4 Sunrun Inc. For: Jun 06 Filed by: STEELE JEANNA
-
Form 4 Sunrun Inc. For: Jun 06 Filed by: Powell Mary
-
Form 4 Sunrun Inc. For: Jun 06 Filed by: Dickson Paul S.
-
Form 4 PACIFIC HEALTH CARE ORGA For: Jun 06 Filed by: KUBOTA TOM
-
Form 4 Sunrun Inc. For: Jun 06 Filed by: Abajian Danny
-
Form 4 Sunrun Inc. For: Jun 05 Filed by: Jurich Lynn Michelle
-
Form 4 MITEK SYSTEMS INC For: Jun 07 Filed by: Wells Donna
-
Form 4 Quince Therapeutics, For: Jun 05 Filed by: McLoughlin Margaret
-
Form 4 Quince Therapeutics, For: Jun 05 Filed by: RYAN UNA S
-
Form 4 Quince Therapeutics, For: Jun 05 Filed by: Senner Christopher J.
-
Form 4 Quince Therapeutics, For: Jun 05 Filed by: Bray June
-
Form 4 Quince Therapeutics, For: Jun 05 Filed by: Benatti Luca
-
Form 4 Quince Therapeutics, For: Jun 05 Filed by: Patni Rajiv
-
Form 144 Warby Parker Inc. Filed by: Blumenthal Neil Harris
-
Form 144 Warby Parker Inc. Filed by: Gilboa David Abraham
-
Form 4 Amprius Technologies, For: Jun 07 Filed by: HSIEH Wen Hsuan
-
Form 4 Endeavor Group Holdings, For: Jun 05 Filed by: Endeavor Executive II Holdco, LLC
-
Form 4 Endeavor Group Holdings, For: Jun 05 Filed by: Whitesell Patrick
-
Form 4 MICROVISION, INC. For: Jun 05 Filed by: Carlile Robert Paul
-
Form 4 MICROVISION, INC. For: Jun 07 Filed by: Markham Drew G
-
Form 4 MICROVISION, INC. For: Jun 05 Filed by: Spitzer Mark Bradley
-
Form 4 MICROVISION, INC. For: Jun 05 Filed by: TURNER BRIAN V
-
Form 4 MICROVISION, INC. For: Jun 05 Filed by: Herbst Jeffrey A
-
Form 4 MICROVISION, INC. For: Jun 05 Filed by: Smith Jada
-
Form 4 MICROVISION, INC. For: Jun 07 Filed by: Verma Anubhav
-
Form 4 Endeavor Group Holdings, For: Jun 05 Filed by: Emanuel Ariel
-
Form 4 MICROVISION, INC. For: Jun 05 Filed by: BIDDISCOMBE SIMON
-
Form 144 Warby Parker Inc. Filed by: Miller Steven Clive
-
Form 4 Endeavor Group Holdings, For: Jun 05 Filed by: Lublin Jason
-
Form 4 Amprius Technologies, For: Jun 07 Filed by: BAYLESS KATHLEEN A
-
Form 4 Amprius Technologies, For: Jun 07 Filed by: Chu Steven
-
Form 4 Outbrain Inc. For: Jun 07 Filed by: Kostman David
-
Form 4 Outbrain Inc. For: Jun 07 Filed by: Kiviat Jason
-
Form 4 Amprius Technologies, For: Jun 07 Filed by: Gustanski Mary
-
Form 4 Outbrain Inc. For: Jun 07 Filed by: Bradshaw Wenkai
-
Form 4 Outbrain Inc. For: Jun 07 Filed by: Galai Yaron
-
Form 4 Amprius Technologies, For: Jun 07 Filed by: MIRRO JUSTIN E
-
Form 4 Amprius Technologies, For: Jun 07 Filed by: DIXON DONALD R
-
Form 3 MICROVISION, INC. For: Jun 05 Filed by: Smith Jada
-
Form 3 MICROVISION, INC. For: Jun 05 Filed by: Schabert Peter
-
Form 4 Aerovate Therapeutics, For: Jun 05 Filed by: RA Capital Healthcare Fund LP
-
Form SC 13D Target Global Acquisitio Filed by: CIIG MANAGEMENT III LLC
-
Form 4 Apogee Therapeutics, For: Jun 05 Filed by: JONES WILLIAM A JR
-
Form 4 W&T OFFSHORE INC For: Jun 05 Filed by: Williford William J
-
Form 4 iHeartMedia, Inc. For: Jun 05 Filed by: Rasulo James A
-
Form 4 iHeartMedia, Inc. For: Jun 05 Filed by: GERSTNER BRAD
